ALPS ETF TR - MED BREAKTHGH (SBIO)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / MED BREAKTHGH
Number of holders
65
Total 13F shares, excl. options
1,444,766
Shares change
-35,124
Total reported value, excl. options
$74,056,022
Value change
-$1,670,344
Put/Call ratio
16%
Number of buys
33
Number of sells
-17
Price
$51.22

Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2020

71 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q4 2020.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,444,766 shares .
Largest 10 shareholders include MORGAN STANLEY (208,185 shares), BANK OF AMERICA CORP /DE/ (199,749 shares), UBS Group AG (198,444 shares), WELLS FARGO & COMPANY/MN (179,348 shares), NTV Asset Management LLC (77,318 shares), Cardan Capital Partners, LLC (52,720 shares), ADVISOR GROUP HOLDINGS, INC. (48,707 shares), NWAM LLC (43,999 shares), COMMONWEALTH EQUITY SERVICES, LLC (41,542 shares), and LPL Financial LLC (40,798 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.